AINewsBreaks Archive - Page 12 of 39

WednesdayJul 30, 2025 9:35 am

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Enterprise Data Monetization With IBM watsonx.ai-Powered Agents

Datavault AI (NASDAQ: DVLT), a platinum partner in IBM Partner Plus, announced the expanded commercialization of its flagship AI agents, DataScore and DataValue, now embedded with IBM watsonx.ai. Designed to turn enterprise data into financial assets, the tools aim to streamline modeling, risk assessment and pricing strategies across on-premises, cloud and hybrid environments. With generative AI projected to add as much as $4.4 trillion annually to major business sectors, the integration positions Datavault AI to help companies tap into the next wave of AI-driven automation and enterprise data monetization. The partnership underscores IBM’s strategy to accelerate AI adoption in industries…

WednesdayJul 30, 2025 9:20 am

AINewsBreaks – AI Maverick Intel, Inc. (OTCID: BINP) Engages IBN to Lead Corporate Communications Strategy

AI Maverick Intel (OTC PINK: BINP), a technology-forward company focused on transforming business customer acquisition through artificial intelligence, selected IBN to manage its corporate communications efforts. AI Maverick Intel’s proprietary platform delivers human-like, AI-powered prospecting with adaptive engagement across sectors including healthcare, biotech, insurance and transportation. Following its May 2025 rebrand and platform acquisition, the company launched an enhanced version in July designed to handle transactional and consultative sales engagements with context-aware messaging and autonomous dialogues. The platform aims to shorten deal cycles and reduce acquisition costs while positioning AI Maverick to capture growth in the AI-in-marketing sector. IBN will…

WednesdayJul 30, 2025 9:10 am

AINewsBreaks – BluSky AI Inc. (OTC: BSAI) Signs LOI to Acquire 15 Acres in Arizona for Modular AI Expansion

BluSky AI (OTC: BSAI), a leading innovator in modular AI infrastructure, signed a Letter of Intent (LOI) to purchase approximately 15 acres of industrial land in Camp Verde, Arizona. The site includes existing electrical infrastructure capable of supporting 1.75 megawatts (MW), with plans to expand to 3.75 MW to meet growing demand. CEO Trent D’Ambrosio said the acquisition reflects BluSky AI’s mission to deliver scalable, energy-efficient compute solutions across the Southwest, positioning its SkyMod technology closer to the edge. The transaction is expected to close later this year with groundbreaking planned for mid-2026. To view the full press release, visit…

TuesdayJul 29, 2025 11:40 am

AINewsBreaks – BluSky AI Inc. (OTC: BSAI) to Acquire Land and 50MW Power Access for Delta Data Center Development

BluSky AI (OTC: BSAI), a modular AI infrastructure innovator, announced it has signed a non-binding letter of intent with Creekstone Energy LLC to acquire 25 acres within the Delta Data Center Development, including access to up to 50 megawatts of scalable power. The site, located within Creekstone’s Delta Gigasite in Utah, will serve as a foundation for BluSky’s next-generation SkyMod compute campuses designed to deliver secure, efficient, and sustainable AI infrastructure. CEO Trent D’Ambrosio said the project underscores BluSky’s commitment to building future-ready modular AI facilities, with groundbreaking anticipated in late 2026. To view the full press release, visit https://ibn.fm/rahsB…

TuesdayJul 29, 2025 11:14 am

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands Commercialization of AI Agents Built on IBM (NYSE: IBM) watsonx.ai

Datavault AI (NASDAQ: DVLT), a leader in AI data experience, valuation, and monetization, announced the expanded commercialization of its flagship AI agents, DataScore(R) and DataValue(R), built on IBM (NYSE: IBM) watsonx.ai. IBM will provide multi-year AI engineering talent and technical expertise to accelerate Datavault’s enterprise-scale offerings across finance, healthcare, sports, entertainment, and government. As a Platinum IBM Partner, Datavault will collaborate with IBM’s sales force and partner network to drive AI adoption and data monetization. CEO Nathaniel Bradley called the collaboration a key milestone in Datavault’s global commercialization roadmap. To view the full press release, visit https://ibn.fm/x93TR About Datavault AI…

TuesdayJul 29, 2025 10:16 am

AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Reports Strong Shareholder Engagement in Virtual Teleconference Highlighting AI-Driven Growth Strategy

Fifty 1 Labs (OTC: FITY), a pioneer in AI-powered health and wellness solutions, successfully hosted its July 28 virtual shareholder teleconference via X (formerly Twitter), outlining its transformative strategy through subsidiary Fifty 1 AI Labs. CEO Paul Arora detailed the company’s AI-driven drug repurposing platform targeting the $320.6 billion functional medicine market and $5.68 trillion biotech sector, supported by a $350,000 personal investment and salary deferrals from management until reaching a $50 million valuation. Key initiatives include a $1 million R&D investment, a targeted $5–10 million biotech acquisition by 2027, and planned uplisting to OTCQB in 2026 and NASDAQ thereafter.…

TuesdayJul 29, 2025 9:45 am

AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Subsidiary FHVH to Showcase Robotics and AI Solutions at California Restaurant Show

Nightfood Holdings (OTCQB: NGTF), through its wholly owned subsidiary Future Hospitality Ventures Holdings Inc. (FHVH) doing business as RoboOp365, announced its participation in the California Restaurant Show from Aug. 3–5, 2025, at the Anaheim Convention Center. Exhibiting at booth 228, FHVH will feature live demonstrations of its AI-enabled kitchen operations and introduce components of its proposed joint venture with Los Angeles Cooking School to create the first U.S. culinary education platform fully integrated with AI, robotics, and automation systems. CEO Sonny Wang said the initiative reflects FHVH’s next phase of execution as it expands its footprint in the $400+ billion…

TuesdayJul 29, 2025 9:35 am

AINewsBreaks – Onar Holding Corporation (OTCQB: ONAR) Expands Strategic Partnership with IQSTEL (NASDAQ: IQST) to Launch AI-Driven Multi-Agentic Operating Infrastructure

Onar (OTCQB: ONAR), a marketing technology company and global agency network, announced an expanded partnership with IQSTEL, Inc. (NASDAQ: IQST) and its AI subsidiary Reality Border to develop a next-generation AI-driven, multi-agentic operating infrastructure. Building on ONAR’s 2024 rebranding of IQSTEL, the initiative will integrate dedicated AI agents for every ONAR employee and client account, streamlining operations, enhancing performance optimization, and enabling real-time strategic insights. CEO Claude Zdanow said the system amplifies human potential by automating repetitive processes while preserving data security. The three-phase rollout will introduce operational streamlining, strategic enablement, and creative augmentation, positioning ONAR at the forefront of…

MondayJul 28, 2025 10:46 am

AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) to Host July 28 Virtual Shareholder Teleconference Featuring Nobel Laureate Dr. James Orbinski

Fifty 1 Labs (OTC: FITY), a leader in AI-powered health and wellness solutions, announced it will host a virtual shareholder teleconference on Monday, July 28, 2025, at 12:00 PM EST. The event, streamed live on X (formerly Twitter), will feature Senior Scientist Dr. James Orbinski, who accepted the 1999 Nobel Peace Prize on behalf of Médecins Sans Frontières (Doctors Without Borders). The teleconference will highlight the company’s strategic roadmap for subsidiary Fifty 1 AI Labs, including AI-driven drug repurposing for functional medicine, a $1 million R&D investment, and plans for a $5–10 million biotech acquisition by 2027. Management underscored alignment…

MondayJul 28, 2025 9:00 am

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics Inc., brings over 20 years of experience in biotechnology leadership and financial markets, with a track record in developing targeted therapies for solid tumors, including HK327M-mutant gliomas. Oncoceutics was acquired by Chimerix Inc. (NASDAQ: CMRX) for $450 million in 2021 and later by Jazz Pharmaceuticals for $935 million in April 2025. Lantern CEO Panna Sharma said Dr. Schalop’s expertise in…

AINewsWire provides insights in the emerging sector of Artificial Intelligence.

Contact us: (512) 354-7000

AINewsBreaks